Vanta Bioscience inks CRO agreement with Emcure Pharmaceuticals

06 Apr 2019 Evaluate

Vanta Bioscience through its step down subsidiary -- Vayam Research Solutions has entered into a non-exclusive CRO Service Agreement with Emcure Pharmaceuticals, Pune, for providing services of Bio-Analytical and Bio-Equivalence services to the said company for a period of three years from 2019 to 2022.

The CRO Service Agreement provides for a minimum revenue assurance between Rs 7 crore to Rs 9 crore for the financial year 2019-2020 and Rs 20 crore for financial year 2020-2021.

Vanta Bioscience is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.


Vanta Bioscience Share Price

23.50 0.00 (0.00%)
31-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 644.00
Indegene 519.60
CMS Info Systems 341.90
Sagility 51.60
Smartworks Coworking 501.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×